Back to Journals » Drug, Healthcare and Patient Safety

Drug, Healthcare and Patient Safety


Journal Articles:

- 156 records -

Older adults and high-risk medication administration in the emergency department

Kim M, Mitchell SH, Gatewood M, Bennett KA, Sutton PR, Crawford CA, Bentov I, Damodarasamy M, Kaplan SJ, Reed MJ

Drug, Healthcare and Patient Safety 2017, 9:105-112

Published Date: 8 November 2017

Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial

Muto S, Okada T, Yasuda M, Tsubouchi H, Nakajima K, Horie S

Drug, Healthcare and Patient Safety 2017, 9:93-104

Published Date: 25 October 2017

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis

Ferguson MJ, Randles ML, de Freitas DG

Drug, Healthcare and Patient Safety 2017, 9:89-91

Published Date: 8 September 2017

Prediction of drug-related problems in diabetic outpatients in a number of hospitals, using a modeling approach

Al-Taani GM, Al-Azzam SI, Alzoubi KH, Darwish Elhajji FW, Scott MG, Alfahel H, Aldeyab MA

Drug, Healthcare and Patient Safety 2017, 9:65-70

Published Date: 28 July 2017

Adaptation of the European Commission-recommended user testing method to patient medication information leaflets in Japan

Yamamoto M, Doi H, Yamamoto K, Watanabe K, Sato T, Suka M, Nakayama T, Sugimori H

Drug, Healthcare and Patient Safety 2017, 9:39-63

Published Date: 14 June 2017

Update on the renal toxicity of iodinated contrast drugs used in clinical medicine

Andreucci M, Faga T, Serra R, De Sarro G, Michael A

Drug, Healthcare and Patient Safety 2017, 9:25-37

Published Date: 22 May 2017

Patient safety attitudes of pharmacy students in an Ethiopian university: a cross-sectional study

Tegegn HG, Abebe TB, Ayalew MB, Bhagavathula AS

Drug, Healthcare and Patient Safety 2017, 9:19-24

Published Date: 8 May 2017

Update on the usage and safety of epinephrine auto-injectors, 2017

Posner LS, Camargo CA Jr

Drug, Healthcare and Patient Safety 2017, 9:9-18

Published Date: 21 March 2017

Development and validation of evaluation tools of nursing students’ clinical pharmacology unit

Navabi N, Ghaffari F, Shamsalinia A, Faghani S

Drug, Healthcare and Patient Safety 2016, 8:101-109

Published Date: 15 December 2016

Topiramate-induced maculopathy in IgG4-related disease

DaCosta J, Younis S

Drug, Healthcare and Patient Safety 2016, 8:59-63

Published Date: 8 June 2016

The virgin land of quality management: a first measure of patient safety climate at the National Hospital of the Faroe Islands

Kristensen S, Túgvustein N, Zachariassen H, Sabroe S, Bartels P, Mainz J

Drug, Healthcare and Patient Safety 2016, 8:49-57

Published Date: 26 April 2016

Seasonality in acute liver injury? Findings in two health care claims databases

Weinstein RB, Schuemie MJ, Ryan PB, Stang PE

Drug, Healthcare and Patient Safety 2016, 8:39-48

Published Date: 31 March 2016

Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia

Bhusal S, Diomampo S, Magrey MN

Drug, Healthcare and Patient Safety 2016, 8:13-23

Published Date: 17 February 2016

A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas

Tribuddharat S, Sathitkarnmanee T, Kitkhuandee A, Theerapongpakdee S, Ngamsaengsirisup K, Chanthawong S

Drug, Healthcare and Patient Safety 2016, 8:9-12

Published Date: 9 February 2016

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis

Pugliese D, Felice C, Landi R, Papa A, Guidi L, Armuzzi A

Drug, Healthcare and Patient Safety 2016, 8:1-7

Published Date: 3 February 2016

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States

Jara M, Aquilina T, Aupperle P, Rabinowicz AL

Drug, Healthcare and Patient Safety 2015, 7:169-174

Published Date: 15 December 2015

Cardiovascular effects of hormone therapy for prostate cancer

Lester JF, Mason MD

Drug, Healthcare and Patient Safety 2015, 7:129-138

Published Date: 23 July 2015

Drug utilization in selected health facilities of South West Shoa Zone, Oromia Region, Ethiopia

Kebede M, Kebebe Borga D, Mulisa Bobasa E

Drug, Healthcare and Patient Safety 2015, 7:121-127

Published Date: 23 July 2015

Cardiovascular effects of basal insulins

Mannucci E, Giannini S, Dicembrini I

Drug, Healthcare and Patient Safety 2015, 7:113-120

Published Date: 10 July 2015

Environmental and host-related determinants of tuberculosis in Metema district, north-west Ethiopia

Tesema C, Tadesse T, Gebrehiwot M, Tsegaw A, Weldegebreal F

Drug, Healthcare and Patient Safety 2015, 7:87-95

Published Date: 27 May 2015

Determinant factors of tobacco use among ever-married men in Bangladesh

Rahman MS, Mondal MNI, Islam MR, Rahman MM, Hoque MN, Alam MS

Drug, Healthcare and Patient Safety 2015, 7:77-85

Published Date: 13 May 2015

Survey on appropriateness of use of nimesulide in nine European countries

Franchi S, Heiman F, Visentin E, Sacerdote P

Drug, Healthcare and Patient Safety 2015, 7:51-55

Published Date: 16 March 2015

Persistent nonmalignant pain management using nonsteroidal anti-inflammatory drugs in older patients and use of inappropriate adjuvant medications

Rianon N, Knell ME, Agbor-Bawa W, Thelen J, Burkhardt C, Rasu RS

Drug, Healthcare and Patient Safety 2015, 7:43-50

Published Date: 29 January 2015

Ability of Saudi mothers to appropriately and accurately use dosing devices to administer oral liquid medications to their children

Almazrou S, Alsahli H, Alwattar H, Alturki L, Alamri M

Drug, Healthcare and Patient Safety 2015, 7:1-6

Published Date: 22 December 2014

Patient perceptions on the subject of medical research

Ventolini G, Goodwin B, Woody C

Drug, Healthcare and Patient Safety 2014, 6:151-153

Published Date: 17 October 2014

Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study

Denholm JT, McBryde ES, Eisen DP, Penington JS, Chen C, Street AC

Drug, Healthcare and Patient Safety 2014, 6:145-149

Published Date: 21 October 2014

Evaluation of bactericidal activity of Hannon honey on slowly growing bacteria in the chemostat

Sufya N, Matar N, Kaddura R, Zorgani A

Drug, Healthcare and Patient Safety 2014, 6:139-144

Published Date: 15 October 2014

Topical steroid addiction in atopic dermatitis

Fukaya M, Sato K, Sato M, Kimata H, Fujisawa S, Dozono H, Yoshizawa J, Minaguchi S

Drug, Healthcare and Patient Safety 2014, 6:131-138

Published Date: 14 October 2014

Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges

Epstein RA, Moore KM, Bobo WV

Drug, Healthcare and Patient Safety 2014, 6:109-129

Published Date: 18 September 2014

Validating administrative data for the detection of adverse events in older hospitalized patients

Ackroyd-Stolarz S, Bowles SK, Giffin L

Drug, Healthcare and Patient Safety 2014, 6:101-108

Published Date: 13 August 2014

Management of L-dopa overdose in the competitive inhibition state

Hinz M, Stein A, Cole T

Drug, Healthcare and Patient Safety 2014, 6:93-99

Published Date: 22 July 2014

Risk-benefit assessment of ivabradine in the treatment of chronic heart failure

Urbanek I, Kaczmarek K, Cygankiewicz I, Ptaszynski P

Drug, Healthcare and Patient Safety 2014, 6:47-54

Published Date: 28 April 2014

Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper

de Araújo AN, do Nascimento MA, de Sena EP, Baptista AF

Drug, Healthcare and Patient Safety 2014, 6:21-27

Published Date: 10 March 2014

Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children

Di Pierro F, Colombo M, Zanvit A, Risso P, Rottoli AS

Drug, Healthcare and Patient Safety 2014, 6:15-20

Published Date: 13 February 2014

Pharmacists’ knowledge and attitudes about natural health products: a mixed-methods study

Kheir N, Gad HY, Abu-Yousef SE

Drug, Healthcare and Patient Safety 2014, 6:7-14

Published Date: 30 January 2014

Oral available agents in the treatment of RRMS

Aupérin T

Drug, Healthcare and Patient Safety 2013, 5:199-201

Published Date: 29 October 2013

Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature

Nasser M, Larsen TR, Waanbah B, Sidiqi I, McCullough PA

Drug, Healthcare and Patient Safety 2013, 5:191-198

Published Date: 26 September 2013

Attrition of Canadian Internet pharmacy websites: what are the implications?

Veronin MA, Clancy KM

Drug, Healthcare and Patient Safety 2013, 5:171-179

Published Date: 15 August 2013

A proposal for a drug information database and text templates for generating package inserts

Okuya R, Kimura M, Ohkura M, Tsuchiya F

Drug, Healthcare and Patient Safety 2013, 5:161-169

Published Date: 29 July 2013

Patient considerations in the use of tapentadol for moderate to severe pain

Vadivelu N, Huang Y, Mirante B, Jacoby M, Braveman FR, Hines RL, Sinatra R

Drug, Healthcare and Patient Safety 2013, 5:151-159

Published Date: 3 July 2013

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin

Jeske W, Walenga JM, Hoppensteadt D, Fareed J

Drug, Healthcare and Patient Safety 2013, 5:133-141

Published Date: 10 June 2013

Risky substance exposure during pregnancy: a pilot study from Lebanese mothers

Rachidi S, Awada S, Al-Hajje A, Bawab W, Zein S, Saleh N, Salameh P

Drug, Healthcare and Patient Safety 2013, 5:123-131

Published Date: 15 May 2013

Non-small cell lung cancer therapy: safety and efficacy in the elderly

Glotzer OS, Fabian T, Chandra A, Bakhos CT

Drug, Healthcare and Patient Safety 2013, 5:113-121

Published Date: 22 April 2013

Clinical use of anti-TNF therapy and increased risk of infections

Ali T, Kaitha S, Mahmood S, Ftesi A, Stone J, Bronze MS

Drug, Healthcare and Patient Safety 2013, 5:79-99

Published Date: 28 March 2013

Clinical utility and tolerability of linagliptin in diabetic patients

Maxwell LG, McFarland MS

Drug, Healthcare and Patient Safety 2013, 5:67-78

Published Date: 22 March 2013

Safety and tolerability of inhalational anticholinergics in COPD

Sharafkhaneh A, Majid H, Gross NJ

Drug, Healthcare and Patient Safety 2013, 5:49-55

Published Date: 8 March 2013

Alcohol and prescription drug safety in older adults

Zanjani F, Hoogland AI, Downer BG

Drug, Healthcare and Patient Safety 2013, 5:13-27

Published Date: 25 February 2013

Antipsychotic agents: efficacy and safety in schizophrenia

de Araújo AN, de Sena EP, de Oliveira IR, Juruena MF

Drug, Healthcare and Patient Safety 2012, 4:173-180

Published Date: 29 November 2012

The economic burden of patient safety targets in acute care: a systematic review

Mittmann N, Koo M, Daneman N, McDonald A, Baker M, Matlow A, Krahn M, Shojanai KG, Etchells E

Drug, Healthcare and Patient Safety 2012, 4:141-165

Published Date: 5 October 2012

Analysis of indoor air pollutants checklist using environmetric technique for health risk assessment of sick building complaint in nonindustrial workplace

Syazwan AI, Mohd Rafee B, Juahir H, Azman AZ, Nizar AM, Izwyn Z, Syahidatussyakirah K, Muhaimin AA, Syafiq Yunos MA, Anita AR, Muhamad Hanafiah J, Shaharuddin MS, Mohd Ibthisham A, Mohd Hasmadi I, Mohamad Azhar MN, Azizan HS, Zulfadhli I, Othman J, Rozalini M, Kamarul FT

Drug, Healthcare and Patient Safety 2012, 4:107-126

Published Date: 21 September 2012

Adverse drug reactions in older patients: an Italian observational prospective hospital study

Conforti A, Costantini D, Zanetti F, Moretti U, Grezzana M, Leone R

Drug, Healthcare and Patient Safety 2012, 4:75-80

Published Date: 17 July 2012

Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap

Page RL 2nd, Ghushchyan V, Allen RR, Roper L, Beck D, Johnathan BH, Frech-Tamas F, Chan W, McQueen RB, Nair KV

Drug, Healthcare and Patient Safety 2012, 4:67-74

Published Date: 10 July 2012

Awareness among nurses about reporting of adverse drug reactions in Sweden

Ekman E, Petersson G, Tågerud S, Bäckström M

Drug, Healthcare and Patient Safety 2012, 4:61-66

Published Date: 28 June 2012

Knowledge of drug prescription in dentistry students

Guzmán-Álvarez R, Medeiros M, Reyes-Lagunes LI, Campos-Sepúlveda AE

Drug, Healthcare and Patient Safety 2012, 4:55-59

Published Date: 19 June 2012

Evaluation of medication package inserts in Saudi Arabia

Al-aqeel SA

Drug, Healthcare and Patient Safety 2012, 4:33-38

Published Date: 26 March 2012

Analysis on descriptions of precautionary statements in package inserts of medicines

Nabeta K, Kimura M, Ohkura M, Tsuchiya F

Drug, Healthcare and Patient Safety 2012, 4:19-25

Published Date: 24 February 2012

Feasibility of home management using ACT for childhood malaria episodes in an urban setting

Nsagha DS, Elat JBN, Ndong PAB, Tata PN, Tayong MN, Pokem F, Wankah CC

Drug, Healthcare and Patient Safety 2012, 4:1-18

Published Date: 29 December 2011

An exploratory study on medications in Qatar homes

Kheir N, El Hajj MS, Wilbur K, Kaissi RML, Yousif A

Drug, Healthcare and Patient Safety 2011, 3:99-106

Published Date: 20 December 2011

Is advertising ethical for dentists? An insight into the Indian scenario

Dable RA, Prasanth MA, Singh SB, Nazirkar GS

Drug, Healthcare and Patient Safety 2011, 3:93-98

Published Date: 16 December 2011

Monoamine depletion by reuptake inhibitors

Hinz M, Stein A, Uncini T

Drug, Healthcare and Patient Safety 2011, 3:69-77

Published Date: 20 October 2011

Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US

Schumock GT, Gibbons RD, Lee TA, Joo MJ, Valuck RJ, Stayner LT

Drug, Healthcare and Patient Safety 2011, 3:47-52

Published Date: 8 September 2011

Trigeminal neuralgia: successful antiepileptic drug combination therapy in three refractory cases

Prisco L, Ganau M, Bigotto F, Zornada F

Drug, Healthcare and Patient Safety 2011, 3:43-45

Published Date: 10 August 2011

Should benefit–risk assessment have its own drug “label”?

Braithwaite RS

Drug, Healthcare and Patient Safety 2011, 3:37-41

Published Date: 3 August 2011

Twelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation

Emoto Y, Emoto H, Oishi E, Hikita S, Wakakura M

Drug, Healthcare and Patient Safety 2011, 3:9-14

Published Date: 3 June 2011

TNF-α inhibitors: are they carcinogenic?

αGirindra Raval, Paulette Mehta

Drug, Healthcare and Patient Safety 2010, 2:241-247

Published Date: 6 December 2010

Insomnia medication use and the probability of an accidental event in an older adult population

Alon Y Avidan, Liisa A Palmer, Justin F Doan, et al

Drug, Healthcare and Patient Safety 2010, 2:225-232

Published Date: 12 November 2010

Safety and tolerability of antipsychotics: focus on amisulpride

Mario F Juruena, Eduardo Pondé de Sena, Irismar Reis de Oliveira

Drug, Healthcare and Patient Safety 2010, 2:205-211

Published Date: 1 October 2010

Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin

Harald Vonkeman, Inger Meek, Mart van de Laar

Drug, Healthcare and Patient Safety 2010, 2:191-204

Published Date: 6 October 2010

Antiepileptic drugs and suicidality

Jeffery W Britton, Jerry J Shih

Drug, Healthcare and Patient Safety 2010, 2:181-189

Published Date: 28 September 2010

Safety and clinical efficacy of golimumab in the treatment of arthritides

Ismail Simsek, Yusuf Yazici

Drug, Healthcare and Patient Safety 2010, 2:169-180

Published Date: 28 September 2010

Profound thrombocytopenia after primary exposure to eptifibatide

Nicholas B Norgard, Brian T Badgley

Drug, Healthcare and Patient Safety 2010, 2:163-167

Published Date: 21 September 2010

Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: Safety, tolerability, and efficacy

Mitchell S Buckley, Robin L Staib, Laura M Wicks, et al

Drug, Healthcare and Patient Safety 2010, 2:151-161

Published Date: 20 September 2010

Antidepressant-associated sexual dysfunction: impact, effects, and treatment

Agnes Higgins, Michael Nash, Aileen M Lynch

Drug, Healthcare and Patient Safety 2010, 2:141-150

Published Date: 9 September 2010

A danger of induction of Brugada syndrome during pill-in-the-pocket therapy for paroxysmal atrial fibrillation

Yoshiyasu Aizawa, Tomohiro Matsuhashi, Toshiaki Sato, et al

Drug, Healthcare and Patient Safety 2010, 2:139-140

Published Date: 25 August 2010

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management

Luca Dalle Carbonare, Mirko Zanatta, Adriano Gasparetto, et al

Drug, Healthcare and Patient Safety 2010, 2:121-137

Published Date: 19 August 2010

Development of indicators for identifying adverse drug events in an Indian tertiary care teaching hospital

Rajakannan Thiyagu, Surulivel R Mallayasamy, Valakkathala Rajesh, et al

Drug, Healthcare and Patient Safety 2010, 2:95-100

Published Date: 30 June 2010

Incorrect description of mode of excretion of linagliptin

Hans-Juergen Woerle, Sanjay Patel

Drug, Healthcare and Patient Safety 2010, 2:93-94

Published Date: 2 June 2010

Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options

Juraj Payer, Kristina Brazdilova, Peter Jackuliak

Drug, Healthcare and Patient Safety 2010, 2:49-59

Published Date: 20 May 2010

Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections

Dionissios Neofytos, Edina Avdic, Anna-Pelagia Magiorakos

Drug, Healthcare and Patient Safety 2010, 2:27-38

Published Date: 20 April 2010

Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers

Elisabet Ekman, Staffan Hägg, Anders Sundström, et al

Drug, Healthcare and Patient Safety 2010, 2:21-25

Published Date: 29 March 2010

Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy

Mary Elizabeth Cox, Jennifer Rowell, Leonor Corsino, et al

Drug, Healthcare and Patient Safety 2010, 2:7-19

Published Date: 28 January 2010

Beyond the black box: drug- and device-associated hypersensitivity events

Charles L Bennett, Olatokunbo S Adegboro, Elizabeth A Calhoun, Dennis Raisch

Drug, Healthcare and Patient Safety 2010, 2:1-5

Published Date: 16 February 2010

Pharmacist-documented interventions during the dispensing process in a primary health care facility in Qatar

Richard Hooper, Abdullah Adam, Nadir Kheir

Drug, Healthcare and Patient Safety 2009, 1:73-80

Published Date: 30 November 2009

Use of X-ray fluoroscopy in orthopedic operations: The patient’s perspective

Zain Ul-Abadin, Faisal rauf Khan, Shams Rauf, Nadia Rauf

Drug, Healthcare and Patient Safety 2009, 1:21-24

Published Date: 18 June 2009

Severe hepatotoxic adverse reaction in a healthy schoolgirl after treatment with flucloxacillin

C-J Törnhage, G Brunlöf, S M Wallerstedt

Drug, Healthcare and Patient Safety 2009, 1:17-19

Published Date: 31 March 2009

Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder

Christine Brady, Shaymaa S Mousa, Shaker A Mousa

Drug, Healthcare and Patient Safety 2009, 1:9-15

Published Date: 3 February 2009